-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
(+/-)-Epigallocatechin-Gallate-13C3
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/epigallocatechin-gallate-13c3.gif)
| Category | Human immunodeficiency Virus (HIV) |
| Description | (+/-)-Epigallocatechin Gallate-13C3 is the 13C-labeled (-)-Epigallocatechin Gallate. (-)-Epigallocatechin Gallate is a tea flavonoid with potent antioxidant, antiinflammatory, and anticarcinogenic properties. (-)-Epigallocatechin Gallate is reported to inhibit EGFR signaling and thereby exert anticancer effects. (-)-Epigallocatechin Gallate (EGCG) is a glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) inhibitor. Epigallocatechin-3-gallate induces oxidative phosphorylation (OXPHOS) by activating cytochrome c oxidase. |
Product Information
| Synonyms | HY-13653S|(+/-)-Epigallocatechin Gallate-13C3 |
| Molecular Weight | 457.32 |
| Molecular Formula | C1913C3H14O11 |
| Boiling Point | 909.1±65.0 °C at 760 mmHg |
| Melting Point | 222-224°C |
| Flash Point | 320.0±27.8 °C |
| Purity | ≥98% (HPLC) |
| Density | 1.9±0.1 g/cm3 |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Index Of Refraction | 1.857 |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
| PSA | 197.37000 |
| Target | Autophagy; Reactive Oxygen Species; HIV; Ferroptosis; Mitochondrial Metabolism; |
| Vapor Pressure | 0.0±0.3 mmHg at 25°C |
